Drugs / Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005
Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00680069 | Nov 2008 → May 2009 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine, Monovalent A/H5N1 A/Indonesia/05/2005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00680069 ↗ |
| Modality | Vaccine | “inactivated monovalent subvirion influenza A/H5N1/Indonesia/05/05 (clade 2) vaccine” NCT00680069 ↗ |
| Route | Intramuscular | “administered via intramuscular injection” NCT00680069 ↗ |